View Future GrowthXIIlabLtd 과거 순이익 실적과거 기준 점검 0/6XIIlabLtd은 연평균 1.3%의 비율로 수입이 증가해 온 반면, Software 산업은 연평균 7.9%의 비율로 증가했습니다. 매출은 연평균 4.5%의 비율로 증가했습니다.핵심 정보1.31%순이익 성장률3.23%주당순이익(EPS) 성장률Software 산업 성장률14.56%매출 성장률4.53%자기자본이익률-12.41%순이익률-30.37%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 20Full year 2024 earnings released: ₩851 loss per share (vs ₩1,063 loss in FY 2023)Full year 2024 results: ₩851 loss per share (improved from ₩1,063 loss in FY 2023). Revenue: ₩9.09b (up 148% from FY 2023). Net loss: ₩5.19b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 33% per year, which means it is performing significantly worse than earnings.Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩307 loss per share (vs ₩268 loss in 2Q 2023)Second quarter 2024 results: ₩307 loss per share (further deteriorated from ₩268 loss in 2Q 2023). Revenue: ₩348.2m (up 3.2% from 2Q 2023). Net loss: ₩1.87b (loss widened 15% from 2Q 2023).Reported Earnings • Mar 22Full year 2023 earnings released: ₩1,063 loss per share (vs ₩754 loss in FY 2022)Full year 2023 results: ₩1,063 loss per share (further deteriorated from ₩754 loss in FY 2022). Revenue: ₩3.66b (down 63% from FY 2022). Net loss: ₩6.46b (loss widened 42% from FY 2022).모든 업데이트 보기Recent updatesNew Risk • Apr 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩64.6b market cap, or US$43.9m).분석 기사 • Apr 18We Think XIIlabLtd (KOSDAQ:189330) Can Easily Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...공지 • Feb 13XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea분석 기사 • Jan 02Here's Why We're Not At All Concerned With XIIlabLtd's (KOSDAQ:189330) Cash Burn SituationJust because a business does not make any money, does not mean that the stock will go down. For example, although...New Risk • Aug 30New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 54% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 9.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩48.4b market cap, or US$34.9m).공지 • Aug 16XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion.XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,050,068 Price\Range: KRW 5800 Discount Per Security: KRW 104.4 Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,290,000 Price\Range: KRW 5800 Discount Per Security: KRW 104.4 Transaction Features: Rights OfferingNew Risk • Jul 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩49.2b market cap, or US$36.4m).New Risk • May 22New major risk - Revenue and earnings growthEarnings have declined by 17% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩40.7b market cap, or US$29.5m).공지 • May 15XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion.XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,290,000 Price\Range: KRW 5430 Discount Per Security: KRW 97.74 Transaction Features: Rights OfferingReported Earnings • Mar 20Full year 2024 earnings released: ₩851 loss per share (vs ₩1,063 loss in FY 2023)Full year 2024 results: ₩851 loss per share (improved from ₩1,063 loss in FY 2023). Revenue: ₩9.09b (up 148% from FY 2023). Net loss: ₩5.19b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 33% per year, which means it is performing significantly worse than earnings.공지 • Feb 25XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea분석 기사 • Dec 05We Think XIIlabLtd (KOSDAQ:189330) Can Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩307 loss per share (vs ₩268 loss in 2Q 2023)Second quarter 2024 results: ₩307 loss per share (further deteriorated from ₩268 loss in 2Q 2023). Revenue: ₩348.2m (up 3.2% from 2Q 2023). Net loss: ₩1.87b (loss widened 15% from 2Q 2023).분석 기사 • Jul 26Is XIIlabLtd (KOSDAQ:189330) In A Good Position To Invest In Growth?Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...Reported Earnings • Mar 22Full year 2023 earnings released: ₩1,063 loss per share (vs ₩754 loss in FY 2022)Full year 2023 results: ₩1,063 loss per share (further deteriorated from ₩754 loss in FY 2022). Revenue: ₩3.66b (down 63% from FY 2022). Net loss: ₩6.46b (loss widened 42% from FY 2022).공지 • Mar 20Xiilab Unveils Cutting-Edge AI Technologies At NVIDIA GTCXiilab announced its participation in the global AI conference, NVIDIA GTC, held in San Jose, California, USA, and online from March 18th to 21st, 2024. Xiilab plans to showcase its AI technology at GTC through three main products: AI video analysis service ('VidiGo'), synthetic data generation solution ('X-GEN'), and GPU orchestration solution. The first product, 'VidiGo,' is a cloud-based AI video analysis service that accurately summarizes the core contents of a video without watching it. It can also quickly search for desired video scenes. Users can easily make a database of characters, objects, and dialogues in the video, which significantly improves work efficiency in the media industry. The second product, 'X-GEN,' is a solution for generating synthetic data for AI model training. Especially in areas like disaster response or defense, there is a shortage of data for AI training. X-GEN can provide synthetic data which can replace real data in such rare conditions, even maximizing AI training performance. Xiilab has been applying 'X-GEN' in the digital twin field using the NVIDIA Omniverse. platform, which provides 3D-workflow and simulation capabilities. Since 2023, Xiilab has been successfully leading digital twin construction projects for global companies. Finally, Xiilab will introduce its GPU efficiency enhancement solution 'astrago' at GTC. Equipped with AI training time prediction technology and AI model management capabilities, 'astrago' is designed to optimize GPU utilization. It predicts the usage time of GPUs and combines AI models suitable for specific services, which can maximize GPU efficiency. Users can significantly reduce the costly expenses associated with GPU usage.분석 기사 • Mar 01We're Not Very Worried About XIIlabLtd's (KOSDAQ:189330) Cash Burn RateThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...New Risk • Nov 12New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2022 fiscal period end). Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 32% over the past year. Minor Risk Market cap is less than US$100m (₩69.5b market cap, or US$52.7m).New Risk • Jul 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue has declined by 32% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Market cap is less than US$100m (₩80.3b market cap, or US$62.8m).Is New 90 Day High Low • Feb 26New 90-day low: ₩36,750The company is down 8.0% from its price of ₩40,000 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 9.0% over the same period.공지 • Feb 25XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021, at 10:00 Korea Standard Time.Is New 90 Day High Low • Jan 19New 90-day high: ₩72,000The company is up 125% from its price of ₩32,050 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 10.0% over the same period.Is New 90 Day High Low • Dec 22New 90-day high: ₩43,700The company is up 36% from its price of ₩32,200 on 23 September 2020. The South Korean market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 9.0% over the same period.Is New 90 Day High Low • Nov 27New 90-day high: ₩40,000The company is up 56% from its price of ₩25,600 on 28 August 2020. The South Korean market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 3.0% over the same period.공지 • Jul 17XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million.XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 50,122 Price\Range: KRW 15960 Transaction Features: Subsequent Direct Listing매출 및 비용 세부 내역XIIlabLtd가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A189330 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 2510,272-3,1192,9782,38530 Sep 259,194-2,9232,6392,08330 Jun 257,956-3,4732,6022,52431 Mar 257,588-4,1102,7322,93231 Dec 249,093-5,1873,0733,20730 Sep 247,824-6,7523,3643,79230 Jun 245,707-7,0673,1783,94431 Mar 245,696-6,8233,0713,91231 Dec 233,663-6,4592,8053,90130 Sep 235,257-5,6542,5513,51430 Jun 239,238-5,1432,8072,86331 Mar 239,418-4,7642,7622,47731 Dec 229,897-4,5452,7262,25031 Dec 215,778-2,1361,7771,352양질의 수익: A189330 은(는) 현재 수익성이 없습니다.이익 마진 증가: A189330는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A189330는 수익성이 없지만 지난 5년 동안 연평균 1.3%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 A189330의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: A189330은 수익성이 없어 지난 해 수익 성장률을 Software 업계(3.6%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A189330는 현재 수익성이 없으므로 자본 수익률이 음수(-12.41%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/08 05:19종가2026/05/08 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스XIIlab Co.,Ltd는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jongsun ParkEugene Investment & Securities Co Ltd.
Reported Earnings • Mar 20Full year 2024 earnings released: ₩851 loss per share (vs ₩1,063 loss in FY 2023)Full year 2024 results: ₩851 loss per share (improved from ₩1,063 loss in FY 2023). Revenue: ₩9.09b (up 148% from FY 2023). Net loss: ₩5.19b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 33% per year, which means it is performing significantly worse than earnings.
Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩307 loss per share (vs ₩268 loss in 2Q 2023)Second quarter 2024 results: ₩307 loss per share (further deteriorated from ₩268 loss in 2Q 2023). Revenue: ₩348.2m (up 3.2% from 2Q 2023). Net loss: ₩1.87b (loss widened 15% from 2Q 2023).
Reported Earnings • Mar 22Full year 2023 earnings released: ₩1,063 loss per share (vs ₩754 loss in FY 2022)Full year 2023 results: ₩1,063 loss per share (further deteriorated from ₩754 loss in FY 2022). Revenue: ₩3.66b (down 63% from FY 2022). Net loss: ₩6.46b (loss widened 42% from FY 2022).
New Risk • Apr 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (₩64.6b market cap, or US$43.9m).
분석 기사 • Apr 18We Think XIIlabLtd (KOSDAQ:189330) Can Easily Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
공지 • Feb 13XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026XIIlab Co.,Ltd, Annual General Meeting, Mar 30, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea
분석 기사 • Jan 02Here's Why We're Not At All Concerned With XIIlabLtd's (KOSDAQ:189330) Cash Burn SituationJust because a business does not make any money, does not mean that the stock will go down. For example, although...
New Risk • Aug 30New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 54% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (14% average weekly change). Earnings have declined by 9.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (54% increase in shares outstanding). Minor Risk Market cap is less than US$100m (₩48.4b market cap, or US$34.9m).
공지 • Aug 16XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion.XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 36.772394 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,050,068 Price\Range: KRW 5800 Discount Per Security: KRW 104.4 Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,290,000 Price\Range: KRW 5800 Discount Per Security: KRW 104.4 Transaction Features: Rights Offering
New Risk • Jul 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 13% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 17% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₩49.2b market cap, or US$36.4m).
New Risk • May 22New major risk - Revenue and earnings growthEarnings have declined by 17% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 17% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Market cap is less than US$100m (₩40.7b market cap, or US$29.5m).
공지 • May 15XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion.XIIlab Co.,Ltd has filed a Follow-on Equity Offering in the amount of KRW 17.8647 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 3,290,000 Price\Range: KRW 5430 Discount Per Security: KRW 97.74 Transaction Features: Rights Offering
Reported Earnings • Mar 20Full year 2024 earnings released: ₩851 loss per share (vs ₩1,063 loss in FY 2023)Full year 2024 results: ₩851 loss per share (improved from ₩1,063 loss in FY 2023). Revenue: ₩9.09b (up 148% from FY 2023). Net loss: ₩5.19b (loss narrowed 20% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 24% per year but the company’s share price has fallen by 33% per year, which means it is performing significantly worse than earnings.
공지 • Feb 25XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025XIIlab Co.,Ltd, Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 513, yeongdong-daero, gangnam-gu, seoul South Korea
분석 기사 • Dec 05We Think XIIlabLtd (KOSDAQ:189330) Can Afford To Drive Business GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Reported Earnings • Aug 17Second quarter 2024 earnings released: ₩307 loss per share (vs ₩268 loss in 2Q 2023)Second quarter 2024 results: ₩307 loss per share (further deteriorated from ₩268 loss in 2Q 2023). Revenue: ₩348.2m (up 3.2% from 2Q 2023). Net loss: ₩1.87b (loss widened 15% from 2Q 2023).
분석 기사 • Jul 26Is XIIlabLtd (KOSDAQ:189330) In A Good Position To Invest In Growth?Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Reported Earnings • Mar 22Full year 2023 earnings released: ₩1,063 loss per share (vs ₩754 loss in FY 2022)Full year 2023 results: ₩1,063 loss per share (further deteriorated from ₩754 loss in FY 2022). Revenue: ₩3.66b (down 63% from FY 2022). Net loss: ₩6.46b (loss widened 42% from FY 2022).
공지 • Mar 20Xiilab Unveils Cutting-Edge AI Technologies At NVIDIA GTCXiilab announced its participation in the global AI conference, NVIDIA GTC, held in San Jose, California, USA, and online from March 18th to 21st, 2024. Xiilab plans to showcase its AI technology at GTC through three main products: AI video analysis service ('VidiGo'), synthetic data generation solution ('X-GEN'), and GPU orchestration solution. The first product, 'VidiGo,' is a cloud-based AI video analysis service that accurately summarizes the core contents of a video without watching it. It can also quickly search for desired video scenes. Users can easily make a database of characters, objects, and dialogues in the video, which significantly improves work efficiency in the media industry. The second product, 'X-GEN,' is a solution for generating synthetic data for AI model training. Especially in areas like disaster response or defense, there is a shortage of data for AI training. X-GEN can provide synthetic data which can replace real data in such rare conditions, even maximizing AI training performance. Xiilab has been applying 'X-GEN' in the digital twin field using the NVIDIA Omniverse. platform, which provides 3D-workflow and simulation capabilities. Since 2023, Xiilab has been successfully leading digital twin construction projects for global companies. Finally, Xiilab will introduce its GPU efficiency enhancement solution 'astrago' at GTC. Equipped with AI training time prediction technology and AI model management capabilities, 'astrago' is designed to optimize GPU utilization. It predicts the usage time of GPUs and combines AI models suitable for specific services, which can maximize GPU efficiency. Users can significantly reduce the costly expenses associated with GPU usage.
분석 기사 • Mar 01We're Not Very Worried About XIIlabLtd's (KOSDAQ:189330) Cash Burn RateThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
New Risk • Nov 12New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended September 2022. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported September 2022 fiscal period end). Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 32% over the past year. Minor Risk Market cap is less than US$100m (₩69.5b market cap, or US$52.7m).
New Risk • Jul 26New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Revenue has declined by 32% over the past year. Minor Risks Latest financial reports are more than 6 months old (reported September 2022 fiscal period end). Market cap is less than US$100m (₩80.3b market cap, or US$62.8m).
Is New 90 Day High Low • Feb 26New 90-day low: ₩36,750The company is down 8.0% from its price of ₩40,000 on 27 November 2020. The South Korean market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 9.0% over the same period.
공지 • Feb 25XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021XIIlab Co.,Ltd, Annual General Meeting, Mar 25, 2021, at 10:00 Korea Standard Time.
Is New 90 Day High Low • Jan 19New 90-day high: ₩72,000The company is up 125% from its price of ₩32,050 on 21 October 2020. The South Korean market is up 26% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Dec 22New 90-day high: ₩43,700The company is up 36% from its price of ₩32,200 on 23 September 2020. The South Korean market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Nov 27New 90-day high: ₩40,000The company is up 56% from its price of ₩25,600 on 28 August 2020. The South Korean market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Software industry, which is up 3.0% over the same period.
공지 • Jul 17XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million.XIIlab Co.,Ltd has completed a Follow-on Equity Offering in the amount of KRW 799.94712 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 50,122 Price\Range: KRW 15960 Transaction Features: Subsequent Direct Listing